Best Buy - Stocks

: Up over 204% YTD following successful Phase 3 trials for its psoriasis therapy.

: Up over 267% YTD after reporting positive clinical data for its RAS/MAPK pathway-driven cancer treatments.

Expert services like Morningstar and The Motley Fool have identified these as top picks for long-term holding. NASDAQ:NVDA best buy stocks

: Up 301% YTD as of April 2026. It is currently the top performer in the S&P 500, benefiting from soaring demand for NAND flash memory used in AI data centers.

: Up over 115% YTD (as of April 27) following a recent 21% surge and bullish outlook on its manufacturing turnaround. Analyst "Best Buy" Recommendations for 2026 : Up over 204% YTD following successful Phase

: Up roughly 394% YTD following the commercial launch of its cancer therapy, Anktiva, in Saudi Arabia and expansion into Europe.

As of late April 2026, the stock market is reaching record highs driven primarily by and semiconductor manufacturing . Analysts are specifically highlighting a "picks and shovels" approach to AI, favoring hardware and storage providers that support data centers. Top-Performing Stocks (Year-to-Date 2026) NASDAQ:NVDA : Up 301% YTD as of April 2026

Several companies have seen triple-digit gains in the first four months of 2026, often led by specialized healthcare breakthroughs or critical AI hardware components.